André de Fusco, CEO of Cynvenio Biosystem’s with one of the firm’s machines. The company’s new technology promises to diagnose cancer from blood samples rather than biopsies. (Stephen Nellis photo) Cynvenio Biosystems has developed a new technology that could revolutionize the way cancer is diagnosed and treated. With the help of new blood-screening technology developed…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
